*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
AIM-listed exploration and development company W Resources has revealed the results of initial assays from its reverse circulation drilling campaign in Portugal.
Molecular diagnostics company Genedrive said it was applying £2m of additional non-dilutive grant funding to progress key development programmes, as it provided investors with a trading update for the year ended 30 June.
Value retailer The Works hopes to raise £62. 2m, split between the business and selling shareholders, in an initial public offer on the London Stock Exchange's main market.
